Dr. Reddy's Allergy Relief D Tablets: Failed Dissolution Risk
Dr. Reddy's recalls Allergy Relief D tablets that may not dissolve properly, potentially affecting medication effectiveness. This recall covers specific lot numbers and packaging sizes sold through Walmart.
Lower-risk recall
Failed dissolution specifications
Contact the company
What happened, in plain English
Dr. Reddy's recalls Allergy Relief D tablets that may not dissolve correctly, which could lead to improper medication delivery. This affects certain lot numbers sold through Walmart. Read more at govinfonow.com/recall/34220-dr-reddy-s-allergy-relief-d-tablets-failed-dissolution-risk.
Source Summary by GovInfoNow · govinfonow.com/recall/34220-dr-reddy-s-allergy-relief-d-tablets-failed-dissolution-risk · Updated August 18, 2026 · FDA enforcement record: FDA #D-0073-2023
Cite this page
“Dr. Reddy's Allergy Relief D Tablets: Failed Dissolution Risk.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/34220-dr-reddy-s-allergy-relief-d-tablets-failed-dissolution-risk. Based on FDA recall #D-0073-2023 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0073-2023%22&limit=1).
Why it’s dangerous
The tablets may not dissolve properly as intended, which could mean the medication isn't released correctly into the body. This might reduce effectiveness but does not pose a direct safety risk like injury or death.
Who’s affected
People who own the specific lot numbers of Allergy Relief D tablets (NDC 49032-273-20 or 49032-273-30) sold through Walmart. Those with the listed expiration dates are most at risk.
How to tell if you have this one
Check for the product name 'Allergy Relief D' with the lot numbers AC2203133B (expiring 01/2024) or AC2203133A (expiring 01/2024). These were sold in 20-count or 30-count cartons through Walmart.
- Brand
Dr. Reddy's- Category
Drug
What to do — step by step
Check Product Details
Look for the lot numbers AC2203133B or AC2203133A on the packaging to confirm if your tablets are affected.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide in the USA” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 21 months after the firm started it.
- Firm started the recall
- FDA classified it Class III
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Questions people ask
What is the specific product being recalled?
Allergy Relief D tablets (Fexofenadine HCL 60mg/Antihistamine, Pseudoephedrine HCL 120mg/Nasal Decongestant, Extended-Release) with lot numbers AC2203133B or AC2203133A.
Do I need to stop using these tablets?
No, the recall is for potential reduced effectiveness, not a safety hazard. You can continue using them if they are not the affected lot numbers.
Similar recalls
Other Dr. Reddy's recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0073-2023 (November 21, 2022) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0073-2023 to see it in context.
- Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.